A soybean genetic innovation leveraging CRISPR-Cas technology to dissect and engineer novel promoter alleles of the GmSHMT08 gene, delivering broad and durable resistance to soybean cyst nematode (SCN)—the most destructive soybean pathogen. This approach addresses the critical limitation of current resistance sources derived from PI88788, which dominate over 93% of US cultivars yet lack effectiveness against multiple SCN races.
Soybean cyst nematode (SCN) is the most destructive pathogen of soybean, causing significant yield losses across major growing regions. Current resistance sources derived from PI88788 are used in over 93% of US soybean cultivars but are not effective against the full spectrum of SCN races, creating an urgent need for broad and durable resistance solutions.
This research focuses on a novel allele associated with the promoter of the GmSHMT08 gene that has been shown to confer resistance to multiple SCN races. The project applies cutting-edge CRISPR-Cas genome-editing technology to dissect the functional role of these novel promoter alleles, with the goal of engineering next-generation soybean varieties with enhanced, broad-spectrum nematode resistance.
Key features:
This research is at an early-to-mid stage of development. The discovery of the novel promoter allele and its association with multi-race SCN resistance has been established through whole-genome haplotype and copy number variation analyses. Future validation will employ CRISPR-Cas-based promoter editing using a hairy-root transformation system to create targeted allelic series and identify the critical cis-regulatory motifs driving resistance. The technology is positioned for further validation and development toward eventual deployment in commercial soybean breeding programs.
Texas Tech University is a large, comprehensive public research university in Lubbock and an anchor of the Texas Tech University System, coupling academic breadth with applied, collaborative research. Industry partners engage through a research park and incubator, co-located labs, shared core facilities, and West Texas field sites for pilot-scale and real-world testing. Proximity to the Permian Basin and regional manufacturing, plus collaboration with the system’s health sciences center, creates clear pathways for product development, clinical translation, and talent pipelines. Research is supported by competitive federal funding from agencies such as NSF, DOE, USDA, NIH, DoD, and NASA, and a dedicated technology transfer office streamlines IP, licensing, startup formation, and corporate contracting.